Applying the Latest Evidence to Delay the Onset of Type 1 Diabetes
In this MEDcast® episode, Diana Isaacs and Natalie Bellini interview Emily Sims, MD, to discuss the latest clinical evidence on teplizumab and other emerging treatments that can delay the onset of type 1 diabetes.
EP. 1: Stages of Type 1 Diabetes and Mechanism of Action of Teplizumab
Dr Emily Sims provides an overview of the stages of type 1 diabetes (T1D) and explains how teplizumab slows the immune-mediated destruction of beta cells.
EP. 2: Study Design and Key Findings from Teplizumab Clinical Trials in Type 1 Diabetes
Dr Emily Sims reviews the study design of the clinical trials with teplizumab and shares key findings from the completed phase 2 trial.
EP. 3: Potential of CGM and other Technology to Screen for Type 1 Diabetes
Expert healthcare practitioners discuss the potential of CGM and other technology to identify signs of type 1 diabetes.
EP. 4: Challenges in Managing Type 1 Diabetes and Pressing Need for New Therapies
Drs Diana Isaacs and Natalie Bellini discuss the everyday challenges of managing type 1 diabetes and underscore the need for new treatments to improve the quality of life for people living with type 1 diabetes
